Rosiglitazone treatment improves insulin regulation and dyslipidemia in type 2 diabetic cynomolgus monkeys. [electronic resource]
Producer: 20041018Description: 1121-5 p. digitalISSN:- 0026-0495
- Animals
- Biomarkers
- Body Weight -- physiology
- C-Reactive Protein -- metabolism
- Diabetes Mellitus, Type 2 -- complications
- Female
- Glucose Tolerance Test
- Hyperlipidemias -- complications
- Hypoglycemic Agents -- therapeutic use
- Insulin -- metabolism
- Lipids -- blood
- Macaca fascicularis
- Male
- Receptors, Cytoplasmic and Nuclear -- agonists
- Rosiglitazone
- Sex Characteristics
- Thiazolidinediones -- therapeutic use
- Transcription Factors -- agonists
- Triglycerides -- blood
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.